Institutional clinical trials supported by the Centre of Evidence of the French Society of Dermatology french version

Project Principal Investigator President of Scientific Committee/SFD thematic groups involved Sponsor Description Funding Status ClinicalTrials.gov number
GALE-SCRATCH Franck BORALEVI Olivier CHOSIDOW / SFDP, GrIDIST, CDP Bordeaux University Hospital Randomised controlled trial comparing the efficacy of 2-dose oral ivermectin versus 5% permethrin to treat scabies in children and adults: SCRATCH trial (SCabies Randomised Trial in CHildren) PHRC National 2011 Published: Download NCT02407782
GALE-CRUSTED Giao DO-PHAM Olivier CHOSIDOW / GrIDIST, CDP  AP-HP Randomised, double-blind, controlled trial evaluating the efficacy of ivermectin 400 µg versus ivermectin 200 µg/kg in severe scabies. GALE-CRUSTED trial. PHRC National 2014 Accepted in the NEJM NCT02841215
SHAREII Tu-Anh DUONG Olivier CHOSIDOW / GrIDIST, CDP  AP-HP Non-inferiority randomized clinical trial comparing a short course of oral amoxicillin vs. standard 10-day treatment for leg erysipelas – SHARE II Study (Short course of Amoxicillin for Erysipelas) PHRC National 2015 The sites are open; the inclusions will start NCT07104552
CONDYVAC Sébastien FOUERE Olivier CHOSIDOW/ GrIDIST, CDP  AP-HP Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response PHRC National 2015 Inclusions closed, analysis scheduled for the end of the follow-up period NCT03296397
SY-DOXY Nicolas DUPIN AP-HP A Randomized Non-Inferiority Clinical Trial of Doxycyline Vs BPG for Early Syphilis PHRC National 2018 Completed. Analysis in progress NCT04838717
SEM-CORTICO Saskia ORO Olivier CHOSIDOW / CDP ASSISTANCE PUBLIQUE AP-HP Severe erythema multiforme: randomized controlled trial comparing short systemic corticosteroid therapy vs. placebo during acute phase PHRC National 2019 Waiting for inclusion to start -
VAC-WARTS Johan CHANAL Olivier CHOSIDOW / GrIDIST, CDP  AP-HP Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts (VAC-WARTS) PHRC National 2019 Recruiting NCT04814446
MADULO Hélène AUBERT Sébastien BARBAROT / GREAT, CDP Nantes University Hospital Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized trial PHRC National 2021 Inclusions closed, analysis scheduled for the end of the follow-up period NCT05642208
ETHNIC Thierry PASSERON Olivier CHOSIDOW / DEFI, CDP Nice University Hospital Randomized controlled trial for moderate acne in people with dark skin phototypes comparing early introduction of oral isotretinoin vs. classical strategy PHRC National 2022 Recruiting NCT06447480
BOOSTERS Bruno MATARD Olivier CHOSIDOW / CDP  AP-HP Use of biologics in folliculitis decalvans PHRC National 2022 Currently being set up -
PRESENT Loïc VAILLANT Olivier CHOSIDOW / GrIDIST, CDP Tours University Hospital Prevention of recurrent leg erysipelas: Compression therapy vs. antibiotics PHRC National 2022 Pending regulatory approval. Scheduled to be set up in April 2026. -
AFTER Guillaume CHABY Olivier CHOSIDOW / DEFI, CDP  AP-HP Treatment for acne in adult women - Efficacy of low-dose isotretinoin versus spironolactone in the initial phase and spironolactone in the maintenance phase: A 2-step randomized controlled trial  PHRC National 2023 Waiting for regulatory approvals -
LEISURE François CHASSET Olivier CHOSIDOW / DEFI, EMSED, CDP  AP-HP Lenalidomide vs. methotrexate in difficult-to-treat cutaneous lupus: a randomized controlled trial PHRC National 2023 It is scheduled to be set up in April 2026, with recruitment beginning in May. -
BOLERO Mahtab SAMIMI GEMUB, CDP CHU DE TOURS Efficacy and safety of baricitinib associated with topical corticosteroids in adult patients with difficult-to-treat oral lichen planus: a randomised, double-blind, placebo-controlled trial  PHRC National 2024 Funding granted, protocol under review following jury selection
OPTIMAD Sébastien BARBAROT CDP, GREAT CHU DE NANTES OPtimal Therapeutic Intervention for Management of moderate-to-severe Atopic Dermatitis: a multi-arm randomized clinical trial PHRC National 2024 Funding granted, protocol under review following jury selection
TINEA TINEA Sophie LEDUCQ SFDP, GrIDIST, CDP CHU DE TOURS High-dose versus standard-dose terbinafine for tinea in children PHRC National 2024 Funding granted, protocol under review following jury selection